Literature DB >> 32555352

The tumor-suppressive role of microRNA-873 in nasopharyngeal carcinoma correlates with downregulation of ZIC2 and inhibition of AKT signaling pathway.

Baotao Lv1, Fuzhou Li1, Xiaoli Liu2, Liqiang Lin3.   

Abstract

Cancer stem cells (CSCs) are responsible for tumor initiation, relapse, and metastasis. Thus, residual CSCs after chemotherapy may result in poor prognosis for nasopharyngeal carcinoma (NPC). Emerging evidence suggests that differentially expressed microRNAs (miRNAs) regulate genes that carry out important functions in CSCs. Here we investigate the interaction of microRNA-873 (miR-873) with the Zic family member 2 (ZIC2) and the effects on downstream serine-threonine protein kinase (AKT) signaling pathway in CSCs in the context of NPC. Initially, microarray-based gene expression profiling identified ZIC2 as a key differentially expressed gene in NPC, which was subsequently confirmed to be upregulated in clinical NPC tissue samples. NPC cells were subjected to sphere-formation conditions in low-attachment plates, followed by sorting of CD133+ cells, which were selected as NPC stem cells after further characterization of stem cell biomarkers. ZIC2 was then shown to be enriched in NPC stem cells at both mRNA and protein levels. However, loss of ZIC2 was associated with the self-renewal, proliferative and tumorigenic properties of NPC stem cells. Next, miRNAs potentially able to target ZIC2 were predicted by the intersection of mirDIP and TargetScan database results, and miRNA miR-873 was found to be downregulated in NPC tissues in general but especially in NPC stem cells. Upregulation of miR-873 inhibited the stem-like properties and tumorigenicity of NPC stem cells, which was found to take place through downregulation of ZIC2 and disruption of the AKT signaling pathway. Collectively, the results obtained suggest that overexpression of miR-873 could aid NPC tumor suppression through reduction of the malignant potential of CSCs.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32555352     DOI: 10.1038/s41417-020-0185-8

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  42 in total

Review 1.  Nasopharyngeal carcinoma: the next challenges.

Authors:  Albiruni R A Razak; Lillian L Siu; Fei-Fei Liu; Emma Ito; Brian O'Sullivan; Kelvin Chan
Journal:  Eur J Cancer       Date:  2010-05-05       Impact factor: 9.162

Review 2.  microRNAs in cancer stem cells: Biology, pathways, and therapeutic opportunities.

Authors:  Zahra Asadzadeh; Behzad Mansoori; Ali Mohammadi; Marjan Aghajani; Khalil Haji-Asgarzadeh; Elham Safarzadeh; Ahad Mokhtarzadeh; Pascal H G Duijf; Behzad Baradaran
Journal:  J Cell Physiol       Date:  2018-12-07       Impact factor: 6.384

Review 3.  Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells.

Authors:  Bin Bao; Aamir Ahmad; Yiwei Li; Asfar S Azmi; Shadan Ali; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Expert Opin Ther Targets       Date:  2012-08-09       Impact factor: 6.902

4.  The zinc finger gene ZIC2 has features of an oncogene and its overexpression correlates strongly with the clinical course of epithelial ovarian cancer.

Authors:  Sergio Marchini; Elizabeth Poynor; Richard R Barakat; Luca Clivio; Michela Cinquini; Robert Fruscio; Luca Porcu; Cecilia Bussani; Maurizio D'Incalci; Eugenio Erba; Michela Romano; Giorgio Cattoretti; Dionyssios Katsaros; Andrew Koff; Lucio Luzzatto
Journal:  Clin Cancer Res       Date:  2012-06-25       Impact factor: 12.531

Review 5.  A major role for microRNAs in glioblastoma cancer stem-like cells.

Authors:  Hong Wei Yang; Hongyan Xing; Mark D Johnson
Journal:  Arch Pharm Res       Date:  2015-02-17       Impact factor: 4.946

6.  ZIC2-dependent OCT4 activation drives self-renewal of human liver cancer stem cells.

Authors:  Pingping Zhu; Yanying Wang; Lei He; Guanling Huang; Ying Du; Geng Zhang; Xinlong Yan; Pengyan Xia; Buqing Ye; Shuo Wang; Lu Hao; Jiayi Wu; Zusen Fan
Journal:  J Clin Invest       Date:  2015-08-31       Impact factor: 14.808

7.  Zic2 promotes tumor growth and metastasis via PAK4 in hepatocellular carcinoma.

Authors:  Shi-Xun Lu; Chris Zhiyi Zhang; Rong-Zhen Luo; Chun-Hua Wang; Li-Li Liu; Jia Fu; Lanjing Zhang; Huamin Wang; Dan Xie; Jing-Ping Yun
Journal:  Cancer Lett       Date:  2017-06-01       Impact factor: 8.679

Review 8.  Nasopharyngeal carcinoma.

Authors:  Melvin L K Chua; Joseph T S Wee; Edwin P Hui; Anthony T C Chan
Journal:  Lancet       Date:  2015-08-28       Impact factor: 79.321

Review 9.  Cancer stem-like cell: a novel target for nasopharyngeal carcinoma therapy.

Authors:  Pingpin Wei; Man Niu; Suming Pan; Yanhong Zhou; Cijun Shuai; Jing Wang; Shuping Peng; Guiyuan Li
Journal:  Stem Cell Res Ther       Date:  2014       Impact factor: 6.832

10.  Addiction of pancreatic cancer cells to zinc-finger transcription factor ZIC2.

Authors:  Shingo Inaguma; Hideaki Ito; Miho Riku; Hiroshi Ikeda; Kenji Kasai
Journal:  Oncotarget       Date:  2015-09-29
View more
  2 in total

1.  Long Noncoding RNA LINC01426 Sequesters microRNA-519d-5p to Promote Non-Small Cell Lung Cancer Progression by Increasing ETS1 Expression.

Authors:  Jixin Dai; Bing Wang; Yueming Zhao; Xuerong Zuo; Hongxia Cui; Xi Chen; Xianhong Liu
Journal:  Cancer Manag Res       Date:  2020-12-10       Impact factor: 3.989

2.  Galectin‑3 facilitates the proliferation and migration of nasopharyngeal carcinoma cells via activation of the ERK1/2 and Akt signaling pathways, and is positively correlated with the inflammatory state of nasopharyngeal carcinoma.

Authors:  Mei Li; Yu Bin Chen; Fen Liu; Jia Quan Qu; Li Cheng Ren; Jin Chai; Can E Tang
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.